RubrYc Therapeutics
RubrYc Therapeutics is a biotechnology company that integrates chemistry and computation to discover and develop antibody-based drugs with unprecedented epitope selectivity.

Year Established: 2018
Stock Ticker:
Exchange:
RubrYc Therapeutics is a biotechnology company that integrates chemistry and computation to discover and develop antibody-based drugs with unprecedented epitope selectivity.


RubrYc Therapeutics is a biotechnology company that integrates chemistry and computation to discover and develop antibody-based drugs with unprecedented epitope selectivity.

RubrYc Therapeutics is a biotechnology company that integrates chemistry and computation to discover and develop antibody-based drugs with unprecedented epitope selectivity.